Seaport Therapeutics, Inc. (SPTX) said it has priced its upsized initial public offering of 14.16 million shares at $18 per share, at the top of the target range.
The company is expected to raise about $254.9 million in gross proceeds from the offering. It has also granted underwriters a 30-day option to purchase an additional 2.12 million shares.
The shares are set to begin trading on the Nasdaq Global Select Market on May 1, 2026 under the ticker "SPTX", with the offering expected to close on May 4, 2026. Goldman Sachs, J.P. Morgan, Leerink Partners, Citigroup, and Stifel are serving as joint book-running managers for the deal.
For comments and feedback contact: editorial@rttnews.com
Business News
April 24, 2026 15:15 ET Economics news flow was relatively light this week even as the conflict in the Middle East continued, raising concerns for policymakers. In the U.S., spending data, initial jobless claims and pending home sales were the highlights. Business confidence in the biggest euro area economy was in focus in Europe. Inflation data from Japan gained attention in Asia.